Recombinant multi-species BIK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BIK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene shares a critical BH3 domain with other death-promoting proteins, such as BID, BAK, BAD and BAX, that is required for its pro-apoptotic activity, and for interaction with anti-apoptotic members of the BCL2 family, and viral survival-promoting proteins. Since the activity of this protein is suppressed in the presence of survival-promoting proteins, it is suggested as a likely target for anti-apoptotic proteins. [provided by RefSeq, Sep 2011]
The Alternative Names of target: Apoptosis inducer NBK,BIK,BIP1,BP4,Bcl-2-interacting killer,Bik,Biklk,Blk,NBK,Nbk

Target products collectionGo to BIK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0421-Ag-1/ GM-Tg-hg-IP0421-Ag-2 Human BIK protein Human
GM-Tg-rg-IP0421-Ag-1/ GM-Tg-rg-IP0421-Ag-2 Rat BIK protein Rat
GM-Tg-mg-IP0421-Ag-1/ GM-Tg-mg-IP0421-Ag-2 Mouse BIK protein Mouse
GM-Tg-cynog-IP0421-Ag-1/ GM-Tg-cynog-IP0421-Ag-2 Cynomolgus/Rhesus macaque BIK protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0421-Ag-1/ GM-Tg-felg-IP0421-Ag-2 Feline BIK protein Feline
GM-Tg-cang-IP0421-Ag-1/ GM-Tg-cang-IP0421-Ag-2 Canine BIK protein Canine
GM-Tg-bovg-IP0421-Ag-1/ GM-Tg-bovg-IP0421-Ag-2 Bovine BIK protein Bovine
GM-Tg-equg-IP0421-Ag-1/ GM-Tg-equg-IP0421-Ag-2 Equine BIK protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0421-Ag-1/ GM-Tg-hg-IP0421-Ag-2; GM-Tg-rg-IP0421-Ag-1/ GM-Tg-rg-IP0421-Ag-2;
GM-Tg-mg-IP0421-Ag-1/ GM-Tg-mg-IP0421-Ag-2; GM-Tg-cynog-IP0421-Ag-1/ GM-Tg-cynog-IP0421-Ag-2;
GM-Tg-felg-IP0421-Ag-1/ GM-Tg-felg-IP0421-Ag-2; GM-Tg-cang-IP0421-Ag-1/ GM-Tg-cang-IP0421-Ag-2;
GM-Tg-bovg-IP0421-Ag-1/ GM-Tg-bovg-IP0421-Ag-2; GM-Tg-equg-IP0421-Ag-1/ GM-Tg-equg-IP0421-Ag-2
Products Name BIK protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BIK
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BIK protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.